Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer
NCT01964534
Interventional
Phase 2
Unknown status
AFUGEM
To evaluate the combination of ABI-007 with gemcitabine or with LV5FU2.
Dec 12,2013
All
18 Years
N/A
18 Years
N/A
114